Search - tctmd.com

Displaying 121 - 140 of 240

Sort: Relevancy | Date

Presentation TCT 2019

Austria Presents: TAVR in a Patient With Anomalous Right Coronary Artery Origin From the Left Aortic Sinus

Presenter: Guy Friedrich

September 26, 2019

News Conference News ESC 2019

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

Yael L. Maxwell

September 12, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Daily News

Safe to Leave Recalled Sprint Fidelis ICD Leads in Place? Debate Continues

Todd Neale

August 28, 2019

News Industry News

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

July 25, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Shelley Wood

May 26, 2019

News Conference News HRS 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Todd Neale

May 20, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Todd Neale

November 11, 2018

Presentation TCT 2018

Featured Case: Late Coronary Sinus Thrombosis After TAVR: An Unexpected and Deadly Event

Presenter: Jorge Cortes Lawrenz, Juan F. Granada, Oscar A. Mendiz, Carlos Cabrera Arroyo, Carlos D Calderas, Anibal A. Damonte, Nabeel Ismaeil

September 24, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Cardiac CTA Radiation Dose Has Dropped by Nearly 80% Over the Last Decade

L.A. McKeown

September 06, 2018

News Conference News ESC 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

Todd Neale

August 27, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

Advertisement

Austria Presents: TAVR in a Patient With Anomalous Right Coronary Artery Origin From the Left Aortic Sinus

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Safe to Leave Recalled Sprint Fidelis ICD Leads in Place? Debate Continues

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Featured Case: Late Coronary Sinus Thrombosis After TAVR: An Unexpected and Deadly Event

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Cardiac CTA Radiation Dose Has Dropped by Nearly 80% Over the Last Decade

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content